Free shipping on all orders over $ 500

BMS-470539 dihydrochloride 

Cat. No. M56259

All AbMole products are for research use only, cannot be used for human consumption.

BMS-470539 dihydrochloride  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

BMS-470539 dihydrochloride is a highly potent and selective melanocortin-1 receptor (MC-1R) agonist with an IC50 of 120 nM, an EC50 of 28 nM.

Chemical Information
Molecular Weight 632.62
Formula C32H43Cl2N5O4
CAS Number 2341796-82-3
Form Solid
Solubility (25°C) DMSO ≥ 100 mg/mL
Water ≥ 100 mg/mL
Storage -20°C, dry, sealed
Related Melanocortin Receptor Products
CRN04894 

CRN04894 is an orally active MC2R antagonist that demonstrates in vivo efficacy in rat model of adrenocorticotropic hormone (ACTH)-stimulated corticosterone secretion.

BMS-470539 

BMS-470539 is a synthetic MC-1R agonist with potent anti-inflammatory properties.

PF-00446687 

PF-00446687 is a potent, selective melanocortin-4 receptor (MC4R) agonist with EC50 of 12 ± 1 nM.

Undecylenoyl phenylalanine 

Undecylenoyl phenylalanine is an antagonist for α-melanocyte-stimulating hormone (MSH) and β-adrenergic receptor (β-ADR) to reduce the melanogenesis in melanocytes.

Adrenocorticotropic Hormone (ACTH) (4-10), human

Adrenocorticotropic Hormone (ACTH) (4-10), human is a melanocortin 4 (MC4R) receptor agonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: BMS-470539 dihydrochloride  supplier, Melanocortin Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.